18.61 USD
+3.95 (+26.94%)
18.62 USD
+0.01 (+0.05%)
Overall FONR gets a fundamental rating of 5 out of 10. We evaluated FONR against 186 industry peers in the Health Care Equipment & Supplies industry. FONR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FONR has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
FONR had positive earnings in the past year.
In the past year FONR had a positive cash flow from operations.
FONR had positive earnings in each of the past 5 years.
In the past 5 years FONR always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of FONR (3.20%) is better than 77.96% of its industry peers.
FONR has a Return On Equity of 4.00%. This is in the better half of the industry: FONR outperforms 75.81% of its industry peers.
FONR has a better Return On Invested Capital (3.80%) than 72.04% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FONR is below the industry average of 8.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.2% | ||
| ROE | 4% | ||
| ROIC | 3.8% |
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
1.3 Margins
The Profit Margin of FONR (6.63%) is better than 79.03% of its industry peers.
In the last couple of years the Profit Margin of FONR has declined.
Looking at the Operating Margin, with a value of 9.66%, FONR is in the better half of the industry, outperforming 77.96% of the companies in the same industry.
FONR's Operating Margin has declined in the last couple of years.
The Gross Margin of FONR (41.07%) is worse than 66.13% of its industry peers.
In the last couple of years the Gross Margin of FONR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.66% | ||
| PM (TTM) | 6.63% | ||
| GM | 41.07% |
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FONR is destroying value.
FONR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for FONR has been reduced compared to 5 years ago.
Compared to 1 year ago, FONR has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.80 indicates that FONR is not a great score, but indicates only limited risk for bankruptcy at the moment.
FONR has a Altman-Z score of 2.80. This is in the better half of the industry: FONR outperforms 70.43% of its industry peers.
The Debt to FCF ratio of FONR is 0.05, which is an excellent value as it means it would take FONR, only 0.05 years of fcf income to pay off all of its debts.
FONR has a better Debt to FCF ratio (0.05) than 94.09% of its industry peers.
FONR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
FONR has a better Debt to Equity ratio (0.00) than 74.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 2.8 |
ROIC/WACC0.43
WACC8.75%
2.3 Liquidity
A Current Ratio of 8.62 indicates that FONR has no problem at all paying its short term obligations.
FONR's Current ratio of 8.62 is amongst the best of the industry. FONR outperforms 90.32% of its industry peers.
FONR has a Quick Ratio of 8.46. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
FONR has a Quick ratio of 8.46. This is amongst the best in the industry. FONR outperforms 90.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.62 | ||
| Quick Ratio | 8.46 |
3. Growth
3.1 Past
FONR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.59%.
The Earnings Per Share has been growing slightly by 0.90% on average over the past years.
FONR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.36%.
FONR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.02% yearly.
EPS 1Y (TTM)-20.59%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-26.41%
Revenue 1Y (TTM)3.36%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%4.34%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.89, which indicates a rather expensive current valuation of FONR.
FONR's Price/Earnings ratio is rather cheap when compared to the industry. FONR is cheaper than 88.17% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.84. FONR is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.89 | ||
| Fwd PE | N/A |
4.2 Price Multiples
FONR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FONR is cheaper than 98.39% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FONR indicates a rather cheap valuation: FONR is cheaper than 94.09% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.4 | ||
| EV/EBITDA | 3.83 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)19.87
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
FONR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
18.61
+3.95 (+26.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.11%
Inst Owner Change-0.51%
Ins Owners4.39%
Ins Owner Change0%
Market Cap136.78M
Revenue(TTM)105.43M
Net Income(TTM)6.99M
Analysts0
Price TargetN/A
Short Float %0.15%
Short Ratio0.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.89 | ||
| Fwd PE | N/A | ||
| P/S | 1.3 | ||
| P/FCF | 18.4 | ||
| P/OCF | 12.11 | ||
| P/B | 0.78 | ||
| P/tB | 0.82 | ||
| EV/EBITDA | 3.83 |
EPS(TTM)1.04
EY5.59%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.01
FCFY5.43%
OCF(TTM)1.54
OCFY8.26%
SpS14.34
BVpS23.79
TBVpS22.77
PEG (NY)N/A
PEG (5Y)19.87
Graham Number23.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.2% | ||
| ROE | 4% | ||
| ROCE | 5.05% | ||
| ROIC | 3.8% | ||
| ROICexc | 5.21% | ||
| ROICexgc | 5.49% | ||
| OM | 9.66% | ||
| PM (TTM) | 6.63% | ||
| GM | 41.07% | ||
| FCFM | 7.05% |
ROA(3y)4.2%
ROA(5y)4.71%
ROE(3y)5.35%
ROE(5y)6.16%
ROIC(3y)5.58%
ROIC(5y)6.68%
ROICexc(3y)7.78%
ROICexc(5y)9.2%
ROICexgc(3y)8.22%
ROICexgc(5y)9.77%
ROCE(3y)7.41%
ROCE(5y)8.87%
ROICexgc growth 3Y-21.28%
ROICexgc growth 5Y-6.2%
ROICexc growth 3Y-21.03%
ROICexc growth 5Y-5.92%
OM growth 3Y-21%
OM growth 5Y-7.01%
PM growth 3Y-14.56%
PM growth 5Y-3.61%
GM growth 3Y-5.13%
GM growth 5Y-3.63%
F-Score5
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 101.91% | ||
| Cap/Sales | 3.67% | ||
| Interest Coverage | 547.62 | ||
| Cash Conversion | 80.82% | ||
| Profit Quality | 106.36% | ||
| Current Ratio | 8.62 | ||
| Quick Ratio | 8.46 | ||
| Altman-Z | 2.8 |
F-Score5
WACC8.75%
ROIC/WACC0.43
Cap/Depr(3y)64.91%
Cap/Depr(5y)77.48%
Cap/Sales(3y)2.95%
Cap/Sales(5y)3.54%
Profit Quality(3y)114.83%
Profit Quality(5y)119.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.59%
EPS 3Y-11.06%
EPS 5Y0.9%
EPS Q2Q%-26.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.36%
Revenue growth 3Y2.25%
Revenue growth 5Y4.02%
Sales Q2Q%4.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.09%
EBIT growth 3Y-19.22%
EBIT growth 5Y-3.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32%
FCF growth 3Y-11.29%
FCF growth 5Y-10.21%
OCF growth 1Y-21.49%
OCF growth 3Y-9.7%
OCF growth 5Y-11.2%
FONAR CORP / FONR FAQ
Can you provide the ChartMill fundamental rating for FONAR CORP?
ChartMill assigns a fundamental rating of 5 / 10 to FONR.
Can you provide the valuation status for FONAR CORP?
ChartMill assigns a valuation rating of 4 / 10 to FONAR CORP (FONR). This can be considered as Fairly Valued.
Can you provide the profitability details for FONAR CORP?
FONAR CORP (FONR) has a profitability rating of 5 / 10.
How financially healthy is FONAR CORP?
The financial health rating of FONAR CORP (FONR) is 8 / 10.